Labetalol S.A.L.F. (Labetalol Hydrochloride)

Labetalol is an antihypertensive agent that acts on both alpha‑1 and beta‑adrenergic receptors to lower blood pressure.

• Hypertension: provides sustained reduction of systemic arterial pressure in chronic hypertension.
• Hypertensive emergencies: enables rapid blood pressure control in acute severe hypertension.
• Pregnancy‑induced hypertension: offers safe blood pressure management when other agents are contraindicated.

• Labetalol exerts a non‑selective blockade of beta‑adrenergic receptors (β1 and β2) together with a selective antagonism of alpha‑1 receptors. This dual action reduces cardiac output through decreased heart rate and contractility while also lowering peripheral vascular resistance, resulting in an overall decline in arterial blood pressure.

Labetalol may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after dose changes.
• Headache: mild to moderate intensity, often transient.
• Fatigue: generalized tiredness without exertion.
• Nausea: occasional upset stomach or urge to vomit.
• Flushing: warm sensation and reddening of the skin.
• Nasal congestion: feeling of blocked nasal passages.

Serious or Rare Side Effects

• Severe hypotension: dangerously low blood pressure requiring medical intervention.
• Bronchospasm: narrowing of airways, particularly in patients with asthma.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Cardiac conduction abnormalities: heart block or arrhythmias.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Acute heart failure: worsening of cardiac function in susceptible individuals.

When using Labetalol, clinicians should observe several safety measures.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Asthma caution: use carefully in patients with reactive airway disease due to possible bronchospasm.
• Hepatic impairment: consider dose adjustment or alternative therapy in liver disease.
• Abrupt discontinuation: avoid sudden stop to prevent rebound hypertension.
• Renal dysfunction: monitor renal function and adjust dosing as needed.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Labetalol can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• MAO inhibitors: risk of severe hypertension.
• Other antihypertensives: additive hypotensive effect.
• Additional beta‑blockers: excessive bradycardia or heart block.
• Calcium channel blockers: heightened blood pressure lowering.
• Clonidine: possible rebound hypertension on withdrawal.

Moderate Interactions (Monitor Closely)

• NSAIDs: may diminish antihypertensive response.
• Diuretics: can cause electrolyte imbalances.
• Insulin or oral hypoglycemics: may mask hypoglycemia symptoms.
• Anesthetic agents: may potentiate cardiovascular depression.
• Certain antidepressants: monitor for altered blood pressure control.